Cargando…
Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact?
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354417/ https://www.ncbi.nlm.nih.gov/pubmed/32685875 http://dx.doi.org/10.1002/rth2.12367 |
_version_ | 1783558079434981376 |
---|---|
author | Shaw, Joseph R. Siegal, Deborah M. |
author_facet | Shaw, Joseph R. Siegal, Deborah M. |
author_sort | Shaw, Joseph R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7354417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73544172020-07-17 Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? Shaw, Joseph R. Siegal, Deborah M. Res Pract Thromb Haemost Commentaries John Wiley and Sons Inc. 2020-05-30 /pmc/articles/PMC7354417/ /pubmed/32685875 http://dx.doi.org/10.1002/rth2.12367 Text en © 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Commentaries Shaw, Joseph R. Siegal, Deborah M. Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? |
title | Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? |
title_full | Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? |
title_fullStr | Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? |
title_full_unstemmed | Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? |
title_short | Prothrombin complex concentrates for DOAC‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: How to gauge the impact? |
title_sort | prothrombin complex concentrates for doac‐associated bleeding, global coagulation assays, and assessments of clinical hemostasis: how to gauge the impact? |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354417/ https://www.ncbi.nlm.nih.gov/pubmed/32685875 http://dx.doi.org/10.1002/rth2.12367 |
work_keys_str_mv | AT shawjosephr prothrombincomplexconcentratesfordoacassociatedbleedingglobalcoagulationassaysandassessmentsofclinicalhemostasishowtogaugetheimpact AT siegaldeborahm prothrombincomplexconcentratesfordoacassociatedbleedingglobalcoagulationassaysandassessmentsofclinicalhemostasishowtogaugetheimpact |